Insider · CIK 0001237305
David L Hauser
director
Files at OGE (OGE ENERGY CORP.), NPO (Enpro Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +49 | $185.86 | $9,107 | 38,246 | Jun 20, 2025 |
| Jun 18, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +14 | $185.86 | $2,650 | 38,260 | Jun 20, 2025 |
| Mar 19, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +52 | $175.76 | $9,140 | 38,182 | Mar 20, 2025 |
| Mar 19, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +15 | $175.76 | $2,646 | 38,197 | Mar 20, 2025 |
| Feb 13, 2025 | NPO Enpro Inc. | AGrant or award Common Stock | +685 | $182.27 | $125k | 3,725 | Feb 13, 2025 |
| Dec 18, 2024 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +50 | $175.86 | $8,793 | 38,115 | Dec 19, 2024 |
| Dec 18, 2024 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +15 | $175.86 | $2,556 | 38,130 | Dec 19, 2024 |
| Dec 10, 2024 | OGE OGE ENERGY CORP. | AGrant or award Stock Equivalent Unitsderivative | +3,793 | $42.18 | $160k | 46,599 | Dec 12, 2024 |
| Dec 5, 2024 | NPO Enpro Inc. | GGift Common Stock | -500 | $0.00 | $0 | 3,040 | Dec 6, 2024 |
| Nov 12, 2024 | NPO Enpro Inc. | GGift Common Stock | -1,000 | $0.00 | $0 | 3,540 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.